← Back to Search

Dental Implant

Short vs Long Dental Implants for Alveolar Bone Loss

N/A

Waitlist Available

Led By Tae-Ju Oh

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Residual bone height under the maxillary sinus between 5 to 7 mm and a width of at least 7 mm, as measured on cone beam computer tomography (CBCT) scans.

Neighboring teeth to the planned implant must have natural root(s) or implant supported restoration.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 month post-op, 12 month post-op, and 24 month post-op visits

Awards & highlights

Study Summary

This trial will compare the outcomes of 5mm and 10mm implants placed in sinus-grafted sites. The primary outcome is bone loss, and the secondary outcomes are surgical time and patient-reported outcomes (satisfaction and post-operative pain).

Who is the study for?

This trial is for adults aged 20-70 needing a dental implant in the upper jaw, who are generally healthy with controlled diabetes if present. They should have good oral hygiene and enough bone under the sinus for the implant. Smokers of more than 10 cigarettes/day, heavy drinkers or drug users, pregnant women, and those with conditions affecting healing aren't eligible.Check my eligibility

What is being tested?

The study compares short (5 mm) versus long (10 mm) dental implants in terms of how well they stay in place over time. It will also look at differences in bone loss around the implants, surgical duration, and patient satisfaction including pain after surgery.See study design

What are the potential side effects?

While not explicitly stated here, common side effects from dental implant surgery can include swelling, bruising, minor bleeding and pain at the implant site. There may be risks associated with longer vs shorter implants that this study aims to uncover.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My jawbone under the sinus has the right height and width for surgery.

Select...

The teeth next to where my implant will go are natural or have implant-supported restorations.

Select...

I am between 20 and 70 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 month post-op, 12 month post-op, and 24 month post-op visits

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 month post-op, 12 month post-op, and 24 month post-op visits

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 month post-op, 12 month post-op, and 24 month post-op visits for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in mesial-distal (M-D) bone loss

Secondary outcome measures

Number of sites with bleeding on probing

Probing pocket depth

Survival rate

Trial Design

2Treatment groups

Experimental Treatment

Group I: Short ImplantExperimental Treatment1 Intervention

17 patients will receive a 5 mm short implant.

Group II: Long ImplantExperimental Treatment1 Intervention

17 patients will receive a sinus lift procedure, bone graft, and 10 mm implant.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,794 Previous Clinical Trials

6,373,882 Total Patients Enrolled

5 Trials studying Alveolar Bone Loss

219 Patients Enrolled for Alveolar Bone Loss

Tae-Ju OhPrincipal InvestigatorUniversity of Michigan

Media Library

Zimmer T3 Short Ex Hex With Discrete Crystalline Deposition (Dental Implant) Clinical Trial Eligibility Overview. Trial Name: NCT04144322 — N/A

Alveolar Bone Loss Research Study Groups: Short Implant, Long Implant

Alveolar Bone Loss Clinical Trial 2023: Zimmer T3 Short Ex Hex With Discrete Crystalline Deposition Highlights & Side Effects. Trial Name: NCT04144322 — N/A

Zimmer T3 Short Ex Hex With Discrete Crystalline Deposition (Dental Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04144322 — N/A

Alveolar Bone Loss Patient Testimony for trial: Trial Name: NCT04144322 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research still open to new participants?

"As indicated on clinicaltrials.gov, this medical study is not open to recruitment at present. Initially posted in October 2019 and last edited November 2022, it stands apart from the other 26 trials which are actively looking for patients currently."

Answered by AI

Does this research endeavor encompass participants aged 70 and above?

"According to the eligibility requirements, patients may join this trial if they are between 20 and 70 years old. Notably, there is a separate study for those under 18 as well as one for seniors above 65."

Answered by AI

Am I eligible to be a part of this investigation?

"This experiment is open to 34 patients aged between 20 and 70 who display a measurable amount of alveolar bone loss. Additional requirements are that the patient has either natural roots or implant-supported restoration in adjacent teeth, displays an overall healthy condition, exhibits full-mouth plaque scores and full-mouth bleeding scores no higher than 30%, have existing teeth/partial prosthesis/implants on the opposite jaw which are expected to generate stable implants at first contact with crowns, and require one premolar or 1st molar dental implant placed within their maxillary region."

Answered by AI